Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
| $31.3M | 0.01% |
677,469
+358,875
| +113% | +$16M |
|
1377
United Therapeutics
UTHR
$22.1B
| $31.2M | 0.01% |
354,450
+10,867
| +3% | +$956K |
|
|
BOLD
1378
DELISTED
Audentes Therapeutics, Inc
BOLD
| $31.2M | 0.01% |
521,541
-34,703
| -6% | -$1.3M |
|
|
SYKE
1379
DELISTED
SYKES Enterprises Inc
SYKE
| $31.1M | 0.01% |
841,502
-10,441
| -1% | -$353K |
|
|
XLRN
1380
DELISTED
Acceleron Pharma
XLRN
| $31.1M | 0.01% |
585,854
+25,942
| +5% | +$1.18M |
|
1381
Marcus Corp
MCS
$884M
| $31M | 0.01% |
975,892
+287
| +0% | +$9.71K |
|
1382
Evertec
EVTC
$1.76B
| $31M | 0.01% |
910,296
+44,032
| +5% | +$1.39M |
|
|
PFPT
1383
DELISTED
Proofpoint, Inc.
PFPT
| $30.9M | 0.01% |
269,476
+3,242
| +1% | +$386K |
|
1384
Global Net Lease
GNL
$1.91B
| $30.9M | 0.01% |
1,524,492
+69,732
| +5% | +$1.38M |
|
1385
NMI Holdings
NMIH
$3.34B
| $30.8M | 0.01% |
929,218
-3,031
| -0.3% | -$94.7K |
|
1386
TripAdvisor
TRIP
$1.28B
| $30.8M | 0.01% |
1,014,360
-287,500
| -22% | -$9.68M |
|
1387
Quaker Houghton
KWR
$2.94B
| $30.7M | 0.01% |
186,592
-3,748
| -2% | -$581K |
|
1388
Nektar Therapeutics
NKTR
$2.55B
| $30.6M | 0.01% |
94,478
-39,160
| -29% | -$11.4M |
|
1389
Boise Cascade
BCC
$2.98B
| $30.6M | 0.01% |
836,424
-5,682
| -0.7% | -$206K |
|
1390
Laureate Education
LAUR
$5.05B
| $30.5M | 0.01% |
1,732,896
+112,492
| +7% | +$1.85M |
|
1391
Essential Properties Realty Trust
EPRT
$6.5B
| $30.5M | 0.01% |
1,229,941
+26,436
| +2% | +$665K |
|
1392
Avis
CAR
$4.97B
| $30.5M | 0.01% |
945,414
-35,446
| -4% | -$1.06M |
|
|
IAA
1393
DELISTED
IAA, Inc. Common Stock
IAA
| $30.4M | 0.01% |
646,816
+2,341
| +0.4% | +$98.6K |
|
1394
Planet Fitness
PLNT
$3.62B
| $30.4M | 0.01% |
407,243
-14,863
| -4% | -$1M |
|
1395
Ollie's Bargain Outlet
OLLI
$4.76B
| $30.4M | 0.01% |
465,245
+1,165
| +0.3% | +$73.8K |
|
1396
Medpace
MEDP
$16.9B
| $30.4M | 0.01% |
361,350
-8,604
| -2% | -$666K |
|
1397
Ultragenyx Pharmaceutical
RARE
$2.66B
| $30.3M | 0.01% |
710,453
-13,724
| -2% | -$566K |
|
|
EPAY
1398
DELISTED
Bottomline Technologies Inc
EPAY
| $30.3M | 0.01% |
565,460
-9,644
| -2% | -$439K |
|
1399
InterDigital
IDCC
$8.72B
| $30.3M | 0.01% |
556,021
-13,251
| -2% | -$732K |
|
|
UHT
1400
Universal Health Realty Income Trust
UHT
$566M
| $30.3M | 0.01% |
258,126
-3,071
| -1% | -$350K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.